Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response

Vaccine

Volumn 14, Issue 6, 1996, Pages 501-505

  Bienzle, U ^a   Bock, H L ^b   Kruppenbacher, J P ^c   Hofmann, F ^d   Vogel, G E ^e   Clemens, R ^b  

^a Institut fur Tropenmedizin   (Germany)

^b SmithKline Beecham   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hepatitis A; Travellers; Vaccination

Indexed keywords

CHOLERA TOXIN; HEPATITIS A VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; TYPHOID VACCINE; VIRUS ANTIBODY; YELLOW FEVER VACCINE;

ADULT; AGE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMANY; HEPATITIS A; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; TRAVEL; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRAVEL; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0029901455     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00224-O     Document Type: Article

References (16)

1. Frösner, G.G., Roggendorf, M., Frösner, H.R. et al. Epidemiology of hepatitis A and B infection in Western European countries and in Germans travelling abroad. In: Viral Hepatitis (1981 International Symposium) (Eds Szmuness, W., Alter, H.J. and Maynard, J.E.). Franklin Institute Press, Philadelphia, 1982, pp. 157-167
2. Steffen, R., Rickenbach, M., Wilhelm, U., Helminger, A. and Schär, M. Health problems after travel to developing countries. J. Infect. Dis. 1987, 156, 84-91
3. Woodson, R.D. and Cahill, K.M. Viral hepatitis abroad -incidence in Catholic missionaries. J. Am. Med. Assoc. 1972, 219, 1191-1193
4. Lange, W.R. Viral hepatitis and international travel. Am. Fam. Phys. 1987, 36, 179-184
5. Steffen, R. Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations. Vaccine 1993, 11, 518-520
6. Stapleton, J. Passive immunization against hepatitis A. Vaccine 1992, 10 Suppl. 1, S45-S47
7. Winokur, P.L. and Stapleton, J.T. Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 1992, 14, 580-586
8. Zaaijer, H.L., Leentvaar-Kuijpers, A., Rotman, H. and Lelie, P.N. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J. Med. Virol. 1993, 40, 22-27
9. Tormans, G., Van Damme, P. and Van Doorselaer, E. Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine 1992, 10 Suppl. 1, S88-S92
10. André, F.E., Hepburn, A. and D'Hondt, E. Inactivated candidate vaccines for hepatitis A. In: Progress in Medical Virology, Vol. 37 (Ed. Melnick, J.L.). Karger, Basel, 1990, pp. 72-95
11. Delem, A. Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response. Biologicals 1992, 20, 289-291
12. Steffen, R. Risk of hepatitis A in travellers. Vaccine 1992, 10 Suppl. 1, S69-S72
13. Nordenfelt, E. Hepatitis A in Swedish travellers. Vaccine 1992, 10 Suppl. 1, S73-S74
14. Gust, I.D. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992, 10 Suppl. 1, S56-S58
15. Bienzle, U., Bock, H.L., Clemens, R., Kruppenbacher, J.P. and Meister, W. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects. Lancet 1993, 341, 1028
16. Müller, R., Chriske, H., Deinhardt, F. et al. Hepatitis A vaccination: schedule for accelerated immunization. Vaccine 1992, 10 Suppl. 1, S124-S125